Clinical Trial

DRug Use & Infections in ViEtnam: TuBerculosis Control

Study acronym: DRIVE-TB
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 30, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
The overarching purpose of the proposed research is to demonstrate that a targeted, multi-component community-based intervention among PWID in Hai Phong will decrease TB prevalence among this very high-risk population.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-12-15; most recent amendment 2025-01-29.
Status change: Not Yet Recruiting → Recruiting 2023-10-27
Trial Details
NCT Number NCT05655702
Lead Sponsor ANRS, Emerging Infectious Diseases
Collaborators: Haiphong University of Medicine and Pharmacy, Expertise France, Université Montpellier, New York University, CENTER FOR SUPPORTING COMMUNITY DEVELOPMENT INITIATIVES
Conditions Tuberculosis
Enrollment 4,000 participants
Start Date 2023-10-02
Primary Completion 2025-11 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-01-30